Which of the following is an example of Type E adverse drug reaction?
**Core Concept**
Type E adverse drug reactions (ADRs) are also known as drug-drug interactions. They occur when two or more medications interact with each other, either by affecting the pharmacokinetics or pharmacodynamics of one or both of the drugs involved. This can lead to an increased risk of adverse effects or reduced efficacy of one or both medications.
**Why the Correct Answer is Right**
Drug-drug interactions can occur through various mechanisms, including competition for the same enzyme or receptor, inhibition of one drug's metabolism by another, or alteration of the pH in the gastrointestinal tract. For example, when a proton pump inhibitor (PPI) is given with a nonsteroidal anti-inflammatory drug (NSAID), the PPI can increase the risk of gastrointestinal bleeding by inhibiting the production of protective stomach acid, while the NSAID can further damage the stomach lining. This is an example of a Type E ADR due to the interaction between the two medications.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it describes a Type A ADR, which is an adverse reaction that is related to the pharmacological effects of the drug. Type A ADRs are predictable and dose-dependent.
**Option B:** This option is incorrect because it describes a Type B ADR, which is an adverse reaction that is not related to the pharmacological effects of the drug. Type B ADRs are unpredictable and not dose-dependent.
**Option D:** This option is incorrect because it describes a side effect, which is a secondary effect of a drug that is not necessarily related to its therapeutic effect.
**Clinical Pearl / High-Yield Fact**
When prescribing multiple medications, it is essential to consider the potential for drug-drug interactions and to monitor patients closely for signs of adverse effects. A thorough review of a patient's medication list and medical history can help identify potential interactions and prevent harm.
**Correct Answer: C.**